ChemicalBook--->CAS DataBase List--->1442657-12-6

1442657-12-6

1442657-12-6 Structure

1442657-12-6 Structure
IdentificationBack Directory
[Name]

Pasotuxizumab
[CAS]

1442657-12-6
[Synonyms]

Pasotuxizumab
Research Grade Pasotuxizumab (DHG01301)
Chemical PropertiesBack Directory
[form ]

Liquid
[color ]

Colorless to light yellow
Hazard InformationBack Directory
[Uses]

Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC)[1][2].
[in vivo]

Pasotuxizumab (0-100 ng/mL approximately, 48 h) leads to activation of CD4+ and CD8+ T cell populations, with EC50s of 3.4-6.7 ng/mL for human cocultures, and 13.7-21.2 ng/mL for cynomolgus monkey cell cocultures[2].
Pasotuxizumab (0-100 ng/mL approximately, 48 h) increases release of interferon-γ, TNF-α, IL-2 and IL-10 in T cells[2].

Animal Model:PC-3-huPSMA mouse xenograft model[2]
Dosage:0.005-5 mg/kg
Administration:i.v., once daily
Result:Inhibited tumor growth by 86% (0.005 mg/kg/d) and 99% (5 mg/kg/d).
Animal Model:BALB/c mice (PK Assay)[2]
Dosage:0.1, 0.3, and 1 mg/kg
Administration:i.v. bolus administration or s.c.
Result:Pharmacokinetic profile of Rafivirumab.
Dose (mg/kg)AUC (mg h/L)CLmatrix (L/h/kg) T1/2 (h) F (%)
i.v. (0.3) 0.93 0.329.7100
s.c. (0.3)0.171118
[References]

[1] Horst-Dieter Hummel, et al. Phase 1 study of pasotuxizumab (BAY 2010112), a PSMA-targeting Bispecific T cell Engager (BiTE) immunotherapy for metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology 2019 37:15_suppl, 5034-5034.
[2] Friedrich M, et al. Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens. Mol Cancer Ther. 2012 Dec;11(12):2664-73. DOI:10.1158/1535-7163.MCT-12-0042
1442657-12-6 suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 17754423994 17754423994
Website: https://www.biochempartner.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Website: http://www.chemstan.com/
Company Name: Biolab Reagents  
Tel: 18108604356 18108604356
Website: www.biolabreagent.com/
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Website: https://www.jknbiochem.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Changsha Fuzhen Biotechnology Co.,LTD  
Tel: 13823398779 13823398779
Website: www.chemicalbook.com/supplier/25777903/
Company Name: Olix (Shanghai) Pharmaceutical Technology Co., Ltd  
Tel: 17316404525
Website: www.olix.cn
Company Name: Atagenix Laboratories  
Tel: 027-87008169 17762441161
Website: www.abinscience.com/
Company Name: AntibodySystem Laboratories SAS  
Tel: 33175446423
Website: www.antibodysystem.com
Company Name: Biosynth Biological Technology (Suzhou) Co Ltd  
Tel: 51288865780
Website: www.biosynth.com
Company Name: Cell Sciences  
Tel: 9785721070
Website: www.cellsciences.com
Tags:1442657-12-6 Related Product Information
1665274-14-5 1807954-17-1 2145109-70-0 2364504-80-1 2102192-68-5 2207590-51-8 2428381-56-8 2252518-85-5 1268714-50-6 1688648-13-6

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.